Both scientists are conducting their research under the supervision and in collaboration with the CRU 5001 Scientific Coordinator, Univ.-Prof. Dr. med. Rittner, Centre for Interdisciplinary Pain Medicine, Dept Anaesthesiology, Intensive Care, Emergency and Pain Medicine, and were recognized during the Conference with awards for best scientific work.
The NeuPSIG Conference was the second occasion this year that Dr. Becker, one of our talented and dedicated clinician scientists, was honored with the Best Poster Award for her outstanding research on CRPS which is being conducted as part of the Project Z. The work titled, " Clinical and histological studies on CRPS patients" sheds light on Complex Regional Pain Syndrome (CRPS), a debilitating condition that has intrigued medical professionals for years. On her work, Dr. Becker identified first clinical as well as histological predictors of pain resolution in CRPS. Both have the potential to transform our understanding of this complex condition, offering hope to all individuals living with chronic pain.
During her medical doctoral thesis, Katharina Mehling, now in her first year in the Dept of Neurosurgery, focused on skin analyses in CRPS patients. The poster "Bilateral deficiency of Meissner corpuscles and papillary blood vessels in early complex regional pain syndrome" offers a new perspective on the early stages of CRPS. Her investigation into the role of Meissner corpuscles and papillary blood vessels in the syndrome provides important information on the neuropathic and vascular symptoms of the disease. Mehling's work holds promise for advancing our ability to diagnose and treat CRPS more effectively.
Her significant contributions have earned her the esteemed recognition of being chosen to deliver an oral presentation at the NeuPSIG trainee data blitz session – a sequence of concise lectures providing a comprehensive overview of the most interesting research presented in the poster session.
The recognition received by Dr. Juliane Becker and Katharina Mehling at NeuPSIG 2023 highlights the importance of the ongoing research within CRU 5001 in advancing our understanding of pain-related disorders. The success of the aforementioned researchers reflects both their individual talents and the collaborative and innovative spirit that defines Prof. Rittner's group. Their dedication to unraveling the complexities of CRPS brings hope to patients around the world, and we applaud their achievements and look forward to witnessing the impact of their research in the years to come.
